Controlled attenuation parameter for assessment of hepatic steatosis grades: a diagnostic meta-analysis
about
Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment.Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B.
P2860
Controlled attenuation parameter for assessment of hepatic steatosis grades: a diagnostic meta-analysis
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Controlled attenuation paramet ...... es: a diagnostic meta-analysis
@ast
Controlled attenuation paramet ...... es: a diagnostic meta-analysis
@en
type
label
Controlled attenuation paramet ...... es: a diagnostic meta-analysis
@ast
Controlled attenuation paramet ...... es: a diagnostic meta-analysis
@en
prefLabel
Controlled attenuation paramet ...... es: a diagnostic meta-analysis
@ast
Controlled attenuation paramet ...... es: a diagnostic meta-analysis
@en
P2093
P2860
P1476
Controlled attenuation paramet ...... es: a diagnostic meta-analysis
@en
P2093
P2860
P304
17654-17663
P577
2015-10-15T00:00:00Z